Location: Home
  • search
  • go
  • Relate News
  • 10/15/2019NMPA Issues New Announcement (2019#83) for Clinical Data Self-Inspecti...
  • 10/15/2019Lonza Tests Water in Chinese CDMO Sector
  • 10/15/2019I-Mab and MorphoSys Approved to Initiate Clinical Trials of TJ202 for ...
  • 10/14/2019Shionogi’s Thrombopoietin Receptor Agonist Lusutrombopag Granted Clin...
  • 10/14/2019Harbour BioMed Completes Phase 2 Chinese Study of HBM9036 for Dry Eye ...
  • 10/12/2019State Council Issues Major New Policy to Stabilize Shortage Drug Suppl...
  • 10/12/2019China Pledges to Make Medical Institutions Elderly-friendly as It Expa...
  • 10/11/2019NHC: Chinese Patient Outcomes Improve Significantly
  • 10/10/2019Innovent and Chi-Med to Evaluate Combo of Sintilimab and Surufatinib i...
  • 10/10/2019China Introduces Policy to Boost Outpatient Reimbursement of Hypertens...
  • 10/10/2019NHSA Introduces BMI Information Business Coding Standards
  • 10/10/2019CDE Solicits Comments on Draft Dossier Requirements for Clinical Trial...
  • 10/10/2019PwC: Biopharma M&As Remain Strong in China
  • 10/9/2019More Chinese Challenge the Use of Traditional Treatments - They Want M...
  • 10/9/2019Insilico Nabs $200M AI-powered Drug Discovery Deal with Chai Tai
  • 10/9/2019The Lancet: China Is Winning Some Health-Care Battles - And Losing Oth...
  • 10/9/2019Chinese Press Urges More Public Services to Care for Alzheimer's Patie...
  • 10/8/2019MSD's KEYTRUDA Approved in First-Line Setting for NSCLC in China
  • 10/3/2019CBMG Builds R&D Center in MD as Its ReJoin Stem Cell Therapy Accep...
  • 10/2/2019NMPA Solicits Comments on the Provisions for Control of Drug Manufactu...
  • 10/1/2019FiercePharma: Big Pharma CEOs' Chinese Names
  • 10/1/2019Central Government Issues Implementation Opinions for Expanding 4+7 Tr...
  • 9/30/2019Financial-related Company News in Brief
  • 9/30/2019Central Government Issues New Policy for Healthcare Sector Development...
  • 9/30/2019Chinese Health Authorities Pledge to Prioritize Rural Development
  • 9/30/2019Erbitux 1L with FOLFOX or FOLFIRI Approved in China for RAS Wild-type ...
  • 9/27/2019NHSA Sets Timeline for Phasing Out Provincial Level Additions of NRDL
  • 9/27/2019Recent Executive Moves
  • 9/27/2019NMPA Confirms Withdrawal of GMP and GSP Certifications, Pledging Timel...
  • 9/26/2019As Tariffs Affect the Pharma Industry, Business Strategies Must Evolve
  • Page:131/357 Total number of articles:10690: [First][<<] [129] [130] [131] [132] [133] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group